Novelion to Cut an Unknown Number of Jobs in Restructuring Post author:Sam Post published:January 25, 2018 Post category:BioPharma Novelion will slash an unknown number of jobs as it initiates “significant cost reduction plans.” Source: BioSpace You Might Also Like AI Firm Exscientia Grabs EUR250 Million Small Molecules Pact With Sanofi May 8, 2017 Neothetics to Slash an Unknown Number of Jobs, Review Strategic Alternatives July 10, 2017 <b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017
<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017